Notes from the Field: Suspected Medetomidine Withdrawal Syndrome Among Fentanyl-Exposed Patients — Philadelphia, Pennsylvania, September 2024–January 2025
MMWR. Morbidity and Mortality Weekly Report · 01.05.2025 · 74 (15) · 266-268
DOI: 10.15585/mmwr.mm7415a2 ↗Kurz gefasst
Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 01.05.2025. Verfasst von Samantha Huo und 10 weiteren Autor:innen. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Medetomidine, a synthetic alpha-2 adrenoreceptor agonist, is a new drug adulterant that was detected in 72% of illegal opioid samples tested in Philadelphia, Pennsylvania, during the last 4 months of 2024.During the same period, detection of xylazine (previously the most common adulterant) decreased from 98% to 31% of samples (1), and health care providers at hospitals in Philadelphia noticed an increasing number of hospitalized patients with a severe drug withdrawal syndrome distinct from fentanyl and xylazine withdrawal, characterized by profound autonomic dysfunction, such as severe hypertension and tachycardia.This report aims to increase awareness of the presence of medetomidine in the illegal opioid supply, characterize the emerging medetomidine withdrawal syndrome, and describe measures to provide effective patient care for this life-threatening syndrome.
Zitieren
APA
Huo, S., London, K., Murphy, L., Casey, E., Durney, P., Arora, M., McKeever, R., Tasillo, A., Goodstein, D., Hart, B., & Perrone, J. (2025). Notes from the Field: Suspected Medetomidine Withdrawal Syndrome Among Fentanyl-Exposed Patients — Philadelphia, Pennsylvania, September 2024–January 2025. MMWR. Morbidity and Mortality Weekly Report, 74(15), 266-268. https://doi.org/10.15585/mmwr.mm7415a2
Vancouver
Huo S, London K, Murphy L, Casey E, Durney P, Arora M, et al. Notes from the Field: Suspected Medetomidine Withdrawal Syndrome Among Fentanyl-Exposed Patients — Philadelphia, Pennsylvania, September 2024–January 2025. MMWR. Morbidity and Mortality Weekly Report. 2025;74(15):266-268. doi:10.15585/mmwr.mm7415a2
BibTeX
@article{Huo2025,
author = {Huo, Samantha and London, Kory and Murphy, Lauren and Casey, Emily and Durney, Philip and Arora, Maya and McKeever, Rita and Tasillo, Abriana and Goodstein, Dennis and Hart, Brendan and Perrone, Jeanmarie},
title = {Notes from the Field: Suspected Medetomidine Withdrawal Syndrome Among Fentanyl-Exposed Patients — Philadelphia, Pennsylvania, September 2024–January 2025},
journal = {MMWR. Morbidity and Mortality Weekly Report},
year = {2025},
volume = {74},
number = {15},
pages = {266--268},
doi = {10.15585/mmwr.mm7415a2}
}
EUVIMED